Detoxification for medication overuse headache is not necessary

Cephalalgia

Volumn 32, Issue 5, 2012, Pages 423-427

  Diener, Hans Christoph ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Chronic migraine; detoxification; medication overuse; onabotulinum toxin A; topiramate

Indexed keywords

BOTULINUM TOXIN A; TOPIRAMATE;

ARTICLE; DISEASE DURATION; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; HUMAN; MIGRAINE; TREATMENT RESPONSE;

ANALGESICS; EVIDENCE-BASED MEDICINE; HEADACHE; HUMANS; TREATMENT OUTCOME;

EID: 84860153587     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102411425867     Document Type: Article

References (17)

1. Silberstein SD, Olesen J, Bousser MG, et al. The International Classification of Headache Disorders, 2nd edition (ICHD-II)-revision of criteria for 8.2 medication-overuse headache. Cephalalgia. 2005 ; 25: 460-465 (Pubitemid 40769867)
2. Mathew NT. Chronic refractory headache. Neurology. 1993 ; 43 (Suppl 3). S26 - S33
3. Radat F, Swendsen J. Psychiatric comorbidity in migraine: a review. Cephalalgia. 2005 ; 25: 165-178 (Pubitemid 40321708)
4. Grande RB, Aaseth K, Benth JS, et al. Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol. 2011 ; 18: 129-137
5. Trucco M, Meineri P, Ruiz L. Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache. J Headache Pain. 2005 ; 6: 334-337 (Pubitemid 41349343)
6. Diener HC, Bussone G, Van Oene J, et al. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2007 ; 27: 814-823 (Pubitemid 46961730)
7. Silberstein SD, Lipton RB, Dodick DW, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache. 2007 ; 47: 170-180
8. Diener HC, Dodick DW, Goadsby PJ, et al. Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia. 2009 ; 29: 1021-1027
9. Aurora S, Dodick D, Turkel C, et al. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 2010 ; 30: 793-803
10. Diener H, Dodick D, Aurora S, et al. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010 ; 30: 804-814
11. Dodick DW, Turkel CC, DeGryse RE, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010 ; 50: 921-936
12. Silberstein S, Joel R, Saper J, et al 62nd Annual Meeting of the American Academy of Neurology. 2010 :
13. Couch JR. Amitriptyline in the prophylactic treatment of migraine and chronic daily headache. Headache. 2010 ; 51: 33-51
14. Krymchantowski AV, Silva MT, Barbosa JS, et al. Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study. Headache. 2002 ; 42: 510-514 (Pubitemid 37011823)
15. Spira P, Beran R. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology. 2003 ; 61: 1753-1759 (Pubitemid 38020824)
16. Yurekli VA, Akhan G, Kutluhan S, et al. The effect of sodium valproate on chronic daily headache and its subgroups. J Headache Pain. 2008 ; 9: 37-41
17. Bartolini M, Silvestrini M, Taffi R, et al. Efficacy of topiramate and valproate in chronic migraine. Clin Neuropharmacol. 2005 ; 28: 277-279 (Pubitemid 44378618)